Diagnostic Yield of Patch Ambulatory Electrocardiogram Monitoring in Children (from a National Registry)

Bolourchi, Meena; Batra, Anjan S.

doi:10.1016/j.amjcard.2014.12.014

Cited by 31 publications

(18 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among these are non-invasive, leadless monitoring patches capable of continuous long-term electrocardiogram (ECG) recording. While the diagnostic yield in CHD patients has not been characterized, a pediatric national registry (n = 3209) showed a substantial diagnostic yield for rhythm monitoring beyond 48 h [19] using the Zio® patch (iRhythm Technologies, Inc., CA, USA), a small, 2 × 5-in. light-weight wire-free 14-day ambulatory ECG adhesive patch monitor that has been FDA-approved.…”

Section: Preprocedural Planning: Rhythm Assessmentmentioning

confidence: 99%

Maximizing the Effectiveness of Ablation for Arrhythmias in the Congenital Heart Patients

Arujuna

Bono

2016

Curr Cardiol Rep

View full text Add to dashboard Cite

Arrhythmias are common in adults with congenital heart disease and account for a large proportion of hospitalizations. The complex anatomical heterogeneity, often in the presence of a delicate hemodynamic system, presents a significant electrophysiological challenge. This review outlines current clinical practice and advances in maximizing the effectiveness of ablation for arrhythmias in congenital heart patients.

show abstract

Section: Preprocedural Planning: Rhythm Assessmentmentioning

confidence: 99%

Maximizing the Effectiveness of Ablation for Arrhythmias in the Congenital Heart Patients

Arujuna

Bono

2016

Curr Cardiol Rep

View full text Add to dashboard Cite

show abstract

“…The prescribed wear time was 14 days in 21 of the 22 included studies, and 7 days in one study. The mean wear time was reported in 13 studies and ranged from 7.0 to 12.8 days, with an unweighted overall mean of 10.4 days (weighted: 9.5 days) 19,22,[27][28][29][30][31][32][33][34][35][36]38 . The median wear time was reported in nine studies and ranged from 5.0 to 14.0 days (7.0-14.0 days among the eighteen studies evaluating adult patients) 17,23,25,26,28,[30][31][32]37 .…”

Section: Device Wear Time and Analyzable Datamentioning

confidence: 99%

“…Five studies reported an unweighted mean of 96.4% (weighted: 96.6%; range: 92.6-98.6%) analyzable time, which refers to the amount of recording time that was free from electrical artifacts and other anomalies that would prevent the processing and analyzing of electrocardiogram signals by ZEUS 22,26,27,29,31 .…”

Section: Device Wear Time and Analyzable Datamentioning

confidence: 99%

Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review

Yenikomshian

Jarvis

Patton

et al. 2019

Current Medical Research and Opinion

View full text Add to dashboard Cite

Objective: Cardiac arrhythmias can be serious and life threatening, and can impose a significant burden on healthcare systems. Recent technological advances in ambulatory electrocardiogram recorders have led to the development of unobtrusive wearable biosensors which allow physicians to study patients' continuous cardiac rhythm data collected over multiple weeks. The objective of this systematic literature review was to summarize evidence on the clinical effectiveness of the Zio 1 patch, a long-term, continuous, uninterrupted cardiac monitoring system. Methods: Findings from searches of MEDLINE, Embase and the Cochrane Central Register of Controlled Trials, as well as grey literature, were screened by two reviewers to identify studies reporting cardiac arrhythmia detection outcomes among patients monitored with Zio for an intended duration 7 days. Results: Twenty-three publications (22 unique studies) were identified. The unweighted mean wear time was 10.4 days (median ranging from 5 to 14 days). The rate of arrhythmia detection increased with monitoring durations >48 h and continued to increase beyond 7 days of monitoring. Across the 22 studies, unweighted mean detection rates for atrial fibrillation (AF; n ¼ 15), supraventricular tachycardia or supraventricular ectopy (n ¼ 15), and ventricular tachycardia (n ¼ 15) were 12.2%, 45.5% and 17.3%, respectively. Unweighted mean detection rates for chronic/sustained AF (n ¼ 5) and paroxysmal AF (n ¼ 5) were 5.6% and 23.3%, respectively. Conclusion: Findings from the review suggest that long-term, continuous, uninterrupted monitoring with Zio results in longer patient wear times and higher cardiac arrhythmia detection rates compared with outcomes reported in previous reviews of short-duration (24-48 h) cardiac rhythm recording studies. ARTICLE HISTORY

show abstract

“…A study by Christine E Tung et al showed that about 15% of first paroxysmal atrial fibrillation occurred after 48 hours, which will not be detected by conventional Holter monitor but can be detected by ZioPatch. The results in a large study among the pediatric age group showed that the mean times to first detected and first symptom‐triggered arrhythmias were 2.7 ± 3.0 and 3.3 ± 3.3 days, respectively.…”

Section: Resultsmentioning

confidence: 99%

Portable out‐of‐hospital electrocardiography: A review of current technologies

Bansal

Joshi

2018

Journal of Arrhythmia

146

View full text Add to dashboard Cite

BackgroundAvailability of portable and home‐based electrocardiography (ECG) is an important medical innovation, which has a potential to transform medical care. We performed this review to understand the current state of out‐of‐hospital portable ECG technologies with respect to their scope, ease of use, data transmission capabilities, and diagnostic accuracy.MethodsWe conducted PubMed and Internet searches for “handheld” or “wearable” or “patch” electrocardiography devices to enlist available technologies. We also searched PubMed with names of individual devices to obtain additional citations. We classified available devices as a “single limb lead ECG recording devices” and chest‐lead “ECG recording devices.” If a device used more than three electrodes, it was defined as a conventional electrocardiography or Holter machine and was excluded from this review.ResultsWe identified a total of 15 devices. Overall, only six of these devices (five single lead and one chest lead) featured in published medical literature as identified from PubMed search. A total of 13 citations were available for the single limb lead ECG recording devices and 6 citations for the chest‐lead ECG recording devices.ConclusionsDespite the increase in number of such devices, published biomedical literature regarding their diagnostic accuracy, reproducibility, or utility is scant.

show abstract

Diagnostic Yield of Patch Ambulatory Electrocardiogram Monitoring in Children (from a National Registry)

Cited by 31 publications

References 18 publications

Maximizing the Effectiveness of Ablation for Arrhythmias in the Congenital Heart Patients

Maximizing the Effectiveness of Ablation for Arrhythmias in the Congenital Heart Patients

Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review

Portable out‐of‐hospital electrocardiography: A review of current technologies

Contact Info

Product

Resources

About